These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12516947)

  • 41. [Ciclesonid--new generation of inhaled glucocorticosteroid].
    Chciałowski A; Płusa T
    Wiad Lek; 2004; 57(1-2):70-3. PubMed ID: 15181753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The FDA-Approved Anti-Asthma Medicine Ciclesonide Inhibits Lung Cancer Stem Cells through Hedgehog Signaling-Mediated SOX2 Regulation.
    Choi HS; Kim SL; Kim JH; Lee DS
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033067
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma.
    Boulet LP; Drollmann A; Magyar P; Timar M; Knight A; Engelstätter R; Fabbri L
    Respir Med; 2006 May; 100(5):785-94. PubMed ID: 16427266
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The efficacy and safety of inhaled corticosteroids: are we ignoring the potential advantages of ciclesonide?
    van der Molen T; Kocks JW
    NPJ Prim Care Respir Med; 2014 May; 24():14013. PubMed ID: 24841448
    [No Abstract]   [Full Text] [Related]  

  • 45. Montelukast--place in therapy.
    Vora AC
    J Assoc Physicians India; 2014 Mar; 62(3 Suppl):46-50. PubMed ID: 25327061
    [No Abstract]   [Full Text] [Related]  

  • 46. Ciclesonide therapy in asthma: a potential effect on small airway inflammation?
    Antoniu SA; Monica Pop C
    Expert Opin Pharmacother; 2009 Apr; 10(5):917-9. PubMed ID: 19351238
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ciclesonide (Alvesco)-a new inhaled corticosteroid for asthma.
    Med Lett Drugs Ther; 2008 Sep; 50(1295):75-6. PubMed ID: 18800024
    [No Abstract]   [Full Text] [Related]  

  • 48. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
    Virchow JC; Bachert C
    Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Equivalent pharmacokinetics of the active metabolite of ciclesonide with and without use of the AeroChamber Plus spacer for inhalation.
    Drollmann A; Nave R; Steinijans VW; Baumgärtner E; Bethke TD
    Clin Pharmacokinet; 2006; 45(7):729-36. PubMed ID: 16802853
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Similar efficacy of ciclesonide versus prednisolone to treat asthma worsening after steroid tapering.
    van den Berge M; Arshad SH; Ind PW; Magnussen H; Hamelmann E; Kanniess F; Postma DS
    Respir Med; 2009 Aug; 103(8):1216-23. PubMed ID: 19297141
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Difference between patient-reported side effects of ciclesonide versus fluticasone propionate.
    van der Molen T; Foster JM; Caeser M; Müller T; Postma DS
    Respir Med; 2010 Dec; 104(12):1825-33. PubMed ID: 20584595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of inhaled ciclesonide on airway responsiveness to inhaled AMP, the composition of induced sputum and exhaled nitric oxide in patients with mild asthma.
    Kanniess F; Richter K; Böhme S; Jörres RA; Magnussen H
    Pulm Pharmacol Ther; 2001; 14(2):141-7. PubMed ID: 11273796
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current treatments for allergic rhinitis and asthma.
    Ortiz G
    JAAPA; 2003 Jul; 16(7):53-6. PubMed ID: 14968500
    [No Abstract]   [Full Text] [Related]  

  • 54. [Antileukotriene drugs in the treatment of obstructive lung diseases and rhinitis].
    Mastalerz L; Kania A
    Pneumonol Alergol Pol; 2010; 78(1):74-8. PubMed ID: 20162522
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between ARIA classification and drug treatment in allergic rhinitis and asthma.
    Antonicelli L; Micucci C; Voltolini S; Senna GE; Di Blasi P; Visonà G; De Marco R; Bonifazi F
    Allergy; 2007 Sep; 62(9):1064-70. PubMed ID: 17686109
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Frequency and impact of allergic rhinitis in asthma patients in everyday general medical practice: a French observational cross-sectional study.
    Magnan A; Meunier JP; Saugnac C; Gasteau J; Neukirch F
    Allergy; 2008 Mar; 63(3):292-8. PubMed ID: 18028246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug approvals: '08 in review. Ciclesonide (Alvesco).
    Laustsen G; Carrillo F; Johnson J; Smith C
    Nurse Pract; 2009 Feb; 34(2):32-4. PubMed ID: 19155883
    [No Abstract]   [Full Text] [Related]  

  • 58. Randomized comparison of the efficacy and safety of ciclesonide and budesonide in adolescents with severe asthma.
    Vermeulen JH; Gyurkovits K; Rauer H; Engelstätter R
    Respir Med; 2007 Oct; 101(10):2182-91. PubMed ID: 17614270
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Updates on the use of inhaled corticosteroids in asthma.
    Stoloff SW; Kelly HW
    Curr Opin Allergy Clin Immunol; 2011 Aug; 11(4):337-44. PubMed ID: 21720220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhaled ciclesonide for outpatients with COVID-19: A meta-analysis.
    Hsu CK; Chao CM; Lai CC
    J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 1):1129-1130. PubMed ID: 35995666
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.